First Trust Advisors LP Mirati Therapeutics, Inc. Transaction History

First Trust Advisors LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$41.27 - $98.62 $590,243 - $1.41 Million	14,302 Added 218.18%	20,857 $945,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $390,022 - $568,318	6,555 New	6,555 $458,000
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $169,758 - $384,557	-4,335 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $3.52 Million - $7.01 Million	-46,405 Reduced 91.46%	4,335 $356,000
Q4 2021 Feb 08, 2022	BUY	$132.01 - $190.29 $6.7 Million - $9.66 Million	50,740 New	50,740 $7.44 Million

Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $532,351 - $714,946	-4,029 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $3.79 Million - $4.73 Million	-26,331 Reduced 86.73%	4,029 $651,000
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $2.12 Million - $2.95 Million	13,332 Added 78.29%	30,360 $5.2 Million
Q4 2020 Feb 02, 2021	BUY	$162.05 - $240.27 $1.37 Million - $2.03 Million	8,429 Added 98.02%	17,028 $3.74 Million
Q3 2020 Nov 05, 2020	BUY	$113.26 - $167.27 $973,922 - $1.44 Million	8,599 New	8,599 $1.43 Million
Q2 2020 Jul 22, 2020	SELL	$72.01 - $120.39 $1.86 Million - $3.11 Million	-25,853 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$69.78 - $116.21 $1.8 Million - $3 Million	25,853 New	25,853 $1.99 Million
Q4 2019 Feb 03, 2020	SELL	$70.76 - $128.86 $1.81 Million - $3.29 Million	-25,535 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$77.91 - $109.6 $1.99 Million - $2.8 Million	25,535 New	25,535 $1.99 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.